NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Scope & Guideline

Catalyzing Advances in Nucleic Acid Science

Introduction

Immerse yourself in the scholarly insights of NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1525-7770
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2000 to 2024
AbbreviationNUCLEOS NUCLEOT NUCL / Nucleosides Nucleotides Nucleic Acids
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS' focuses on the biochemical and molecular aspects of nucleosides, nucleotides, and nucleic acids with an emphasis on their implications in health, disease, and therapeutic applications. It serves as a platform for disseminating cutting-edge research that bridges molecular biology and medicinal chemistry.
  1. Genetic Polymorphisms and Disease Associations:
    Research frequently explores the associations between genetic polymorphisms in nucleic acid-related genes and various diseases, including cancer, metabolic disorders, and infectious diseases. This area aims to elucidate how these genetic variations impact disease susceptibility and progression.
  2. Nucleotide Metabolism and Therapeutics:
    The journal publishes studies on the metabolism of nucleotides and their role in therapeutic contexts, particularly in cancer treatment and drug development. This includes investigations into nucleoside analogs and their mechanisms of action.
  3. Molecular Biology Techniques and Innovations:
    There is a strong emphasis on methodological advancements in molecular biology techniques, including the synthesis of nucleoside derivatives, oligonucleotide synthesis, and innovative analytical methods such as mass spectrometry and bioinformatics.
  4. MicroRNAs and Long Non-Coding RNAs:
    The exploration of microRNAs and long non-coding RNAs in gene regulation, cancer biology, and their potential as biomarkers or therapeutic targets is a key focus area.
  5. Bioinformatics and Computational Biology:
    The journal features research that employs bioinformatics tools and computational modeling to understand nucleic acid interactions, predict gene functions, and analyze large genomic datasets.
The journal has seen a notable evolution in its thematic focus, reflecting broader trends in biomedical research. Emerging themes highlight the journal's adaptability to current scientific challenges and innovations.
  1. COVID-19 and Infectious Disease Research:
    The impact of the COVID-19 pandemic has led to a surge in research related to genetic susceptibility, antiviral treatments, and the role of nucleotides in immune responses against infections.
  2. Cancer Genomics and Precision Medicine:
    There is an increasing emphasis on cancer genomics, particularly studies linking genetic variations and tumor biology to precision medicine approaches, which tailor treatments based on individual genetic profiles.
  3. Functional Role of Non-Coding RNAs:
    Research into the functional roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is gaining prominence, with implications for cancer biology, gene regulation, and therapeutic applications.
  4. Metabolomics and Nucleotide Profiling:
    Emerging studies are focusing on metabolomic profiling of nucleotides and their metabolites in various biological contexts, providing insights into metabolic pathways and disease states.
  5. Advanced Drug Delivery Systems:
    Research on innovative drug delivery systems, particularly those utilizing nucleic acids for targeted therapy, is on the rise, reflecting the growing interest in nucleic acid-based therapeutics.

Declining or Waning

While the journal maintains a robust publication record, certain themes have shown a decline in prevalence over the years. This may reflect shifting research priorities or advancements in methodology that render previous approaches less relevant.
  1. Traditional Antiviral Agents:
    Research focused on classical antiviral nucleoside analogs has decreased, possibly due to the rise of novel therapeutic approaches like RNA interference and CRISPR technology, which offer alternative strategies for viral infections.
  2. Basic Nucleotide Biochemistry:
    Studies that solely emphasize the biochemistry of nucleotides without clinical or therapeutic implications have waned. The journal's focus has increasingly shifted towards applications and translational research.
  3. Plant-Based Nucleotide Sources:
    Research into naturally occurring nucleosides and their extraction from plant sources has become less prominent, as synthetic and semi-synthetic approaches gain more attention for their efficiency and specificity.

Similar Journals

BIOCHEMICAL GENETICS

Innovating the Understanding of Genetic Mechanisms
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0006-2928Frequency: 6 issues/year

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

IUBMB LIFE

Connecting Researchers to the Future of Life Sciences
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

Biomolecules

Where groundbreaking research meets open access knowledge.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

RNA Biology

Elevating RNA Studies to New Heights
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6286Frequency: 12 issues/year

RNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.

Reports of Biochemistry and Molecular Biology

Innovating the future of biochemical science.
Publisher: VARASTEGAN INST MEDICAL SCIENCESISSN: 2322-3480Frequency: 2 issues/year

Reports of Biochemistry and Molecular Biology, published by VARASTEGAN INST MEDICAL SCIENCES, is a distinguished open access journal dedicated to advancing the fields of biochemistry and molecular biology. Since its inception in 2012, the journal has fostered a platform for researchers and professionals to disseminate their findings, contributing to a richer understanding of biochemical processes and molecular mechanisms. With a focus on innovative research and technology, the journal has established itself as a significant resource within its field, being classified in the Q3 category for Biochemistry and Molecular Biology by 2023. Notably, it has achieved respectable Scopus rankings, including a rank of #40/72 in Biochemistry (medical) as well as a common ground across multiple related categories. The journal’s commitment to open access ensures that its valuable content is freely available to the global scientific community, facilitating knowledge sharing among students, researchers, and professionals alike. Located in Mashhad, Iran, Reports of Biochemistry and Molecular Biology serves as a bridge between cutting-edge research and practical applications in the biochemistry and molecular biology domains.

MOLECULAR BIOLOGY

Innovating Insights into Biochemistry and Genetics
Publisher: PLEIADES PUBLISHING INCISSN: 0026-8933Frequency: 6 issues/year

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.

Non-coding RNA Research

Exploring the Frontiers of Molecular Biology
Publisher: KEAI PUBLISHING LTDISSN: 2468-2160Frequency: 4 issues/year

Non-coding RNA Research, published by KEAI PUBLISHING LTD, is a leading open-access journal dedicated to advancing the field of non-coding RNA, a critical component in the landscape of molecular biology and genetics. Established in 2016, this journal aims to provide a platform for the dissemination of high-quality research focusing on the roles, mechanisms, and therapeutic potentials of non-coding RNAs in various biological processes and diseases. With impressive Scopus rankings placing it in the top quartile for both Biochemistry and Medical Biochemistry, as well as notable standings in Genetics and Molecular Biology, Non-coding RNA Research continues to attract contributions from globally recognized experts. The journal's commitment to open access ensures broad visibility and engagement with cutting-edge discoveries, thereby fostering an inclusive scientific dialogue that enhances understanding and innovation in this rapidly evolving field. For researchers and scholars, the opportunity to publish in a Q1 ranked journal not only validates their work but also enhances its impact, making Non-coding RNA Research an indispensable resource for anyone interested in the intricate workings of non-coding RNA.

Non-Coding RNA

Transforming Perspectives on Molecular Biology
Publisher: MDPIISSN: Frequency: 6 issues/year

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

Biochemistry and Cell Biology

Advancing the frontiers of biochemistry and cell biology.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

MOLECULAR AND CELLULAR BIOLOGY

Fostering Insights into Life's Molecular Foundations
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.